Publications by authors named "Janet de Beukelaar"

Claim this Profile
B
Bilateral Sylvian fissure lipomas with angiomatous component: A case report.
Mireille M de Vries, Nadine Oosterhof, Carine Martins Jarnalo, Marjolein Dremmen, Janet de Beukelaar

Radiol Case Rep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perturbances in Both Circulating B and CD4 T Cells Discriminate Multiple Sclerosis from Other Central Nervous System Autoimmune Diseases.
Laurens Bogers, Jasper Rip, Suzanne C Franken, Kirsten L Kuiper, Ana M Marques, Janet de Beukelaar

Eur J Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse or no relapse in multiple sclerosis: Can disease activity biomarkers support the clinician?
Jeske van Pamelen, Marleen J A Koel-Simmelink, Birgit I Lissenberg, Edo P J Arnoldus, Janet de Beukelaar

Mult Scler J Exp Transl Clin· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The liminal space between hope and grief: The phenomenon of uncertainty as experienced by people living with relapsing-remitting multiple sclerosis.
Eva C van Reenen, Inge A M van Nistelrooij, Leo H Visser, Janet W K de Beukelaar, Stephan T F M Frequin

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot study.
Jeske van Pamelen, Carla Rodriguez-Mogeda, Lynn van Olst, Susanne M A van der Pol, Maarten L Boon, Janet de Beukelaar

Front Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical Trial.
Eline M E Coerver, Wing Hee Fung, Janet de Beukelaar, Willem H Bouvy, Leo R Canta

JAMA Neurol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifaceted Biomarkers Suggest a Similar Profile of CNS Pathology in Relapsing and Progressive MS.
Katelijn M Blok, Romy A M Klein Kranenbarg, Kirtana Ananth, Hendrik J Engelenburg, Aletta van den Bosch, Janet de Beukelaar

Eur J Neurol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reasons Patients With Primary Progressive Multiple Sclerosis Contact Their Specialist Nurses.
Rosaline van den Berg, Katelijn Blok, Nura Tebayna, Monique van Dijk, Joost van Rosmalen, Janet de Beukelaar

Int J MS Care· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocrelizumab associates with reduced cerebrospinal fluid B and CD20 CD4 T cells in primary progressive multiple sclerosis.
Fabiënne van Puijfelik, Katelijn M Blok, Romy A M Klein Kranenbarg, Jasper Rip, Janet de Beukelaar

Brain Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world challenges in the diagnosis of primary progressive multiple sclerosis.
Katelijn M Blok, Joost Smolders, Joost van Rosmalen, Carine O Martins Jarnalo, Beatrijs Wokke, Janet de Beukelaar

Eur J Neurol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis.
Katelijn M Blok, Joost van Rosmalen, Nura Tebayna, Joost Smolders, Beatrijs Wokke, Janet de Beukelaar

Front Neurol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome.
Roos M van der Vuurst de Vries, Julia Y Mescheriakova, Yu Yi M Wong, Tessel F Runia, Naghmeh Jafari, Janet W K de Beukelaar

JAMA Neurol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease.
Peter Maat, Janet W de Beukelaar, Casper Jansen, Maaike Schuur, Cornelia M van Duijn

Neurol Neuroimmunol Neuroinflamm· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-DQ2+ individuals are susceptible to Hu-Ab associated paraneoplastic neurological syndromes.
Marieke T de Graaf, Janet W K de Beukelaar, Geert W Haasnoot, Wilfried H B M Levering, Véronique Rogemond

J Neuroimmunol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Juxta facet cyst of the lumbar spine: an uncommon cause of lumbar radiculopathy].
Janet W K de Beukelaar, Alof Dallenga, Gert-Jan de Jong, Koos J A Ruizeveld de Winter, Stef L M Bakker

Ned Tijdschr Geneeskd· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence for the presence of HuD-specific T cells in the cerebrospinal fluid of patients with Hu-associated paraneoplastic neurological syndromes.
Janet W de Beukelaar, Johannes C Milikan, Georges M Verjans, Marieke T de Graaf, Yvette van Norden

J Neurol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contamination of synthetic HuD protein spanning peptide pools with a CMV-encoded peptide.
Marieke T de Graaf, Janet W de Beukelaar, Peter C Burgers, Theo M Luider, Jaco Kraan

Cytometry A· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B and T cell imbalances in CSF of patients with Hu-antibody associated PNS.
Marieke de Graaf, Janet de Beukelaar, Jelmer Bergsma, Jaco Kraan, Martin van den Bent

J Neuroimmunol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.
Janet W de Beukelaar, Georges M Verjans, Yvette van Norden, Johannes C Milikan, Jaco Kraan

Cancer Immunol Immunother· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of impurities in synthetic peptides on the outcome of T-cell stimulation assays.
Janet W de Beukelaar, Jan W Gratama, Peter A Sillevis Smitt, Georges M Verjans, Jaco Kraan

Rapid Commun Mass Spectrom· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing paraneoplastic neurological disorders.
Janet W de Beukelaar, Peter A Sillevis Smitt

Oncologist· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes.
Setareh Shams'ili, Janet de Beukelaar, Jan Willem Gratama, Herbert Hooijkaas, Martin van den Bent

J Neurol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolution of EBV(+) CNS lymphoma with appearance of CSF EBV-specific T cells.
Janet W de Beukelaar, Cornelis van Arkel, Martin J van den Bent, Mars B van't Veer, Gerard J van Doornum

Ann Neurol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How stressful can it be to catch a thief? The influence of stress on calcium metabolism.
Janet W K de Beukelaar, Huib A P Pols, M Carola Zillikens, Paula van Biezen, Paul L A van Daele

Am J Med· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis